Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”

Detalles Bibliográficos
Autores principales: Roseweir, Antonia K., McMillan, Donald C., Edwards, Joanne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189185/
https://www.ncbi.nlm.nih.gov/pubmed/30297771
http://dx.doi.org/10.1038/s41416-018-0275-7
_version_ 1783363311832662016
author Roseweir, Antonia K.
McMillan, Donald C.
Edwards, Joanne
author_facet Roseweir, Antonia K.
McMillan, Donald C.
Edwards, Joanne
author_sort Roseweir, Antonia K.
collection PubMed
description
format Online
Article
Text
id pubmed-6189185
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-61891852019-10-09 Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer” Roseweir, Antonia K. McMillan, Donald C. Edwards, Joanne Br J Cancer Correspondence Nature Publishing Group UK 2018-10-09 2018-10-02 /pmc/articles/PMC6189185/ /pubmed/30297771 http://dx.doi.org/10.1038/s41416-018-0275-7 Text en © Cancer Research UK 2018 https://creativecommons.org/licenses/by/4.0/This work is published under the standard license to publish agreement. After 12 months the work will become freely available and the license terms will switch to a Creative Commons Attribution 4.0 International (CC BY 4.0).
spellingShingle Correspondence
Roseweir, Antonia K.
McMillan, Donald C.
Edwards, Joanne
Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
title Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
title_full Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
title_fullStr Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
title_full_unstemmed Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
title_short Reply to comment of “ERK and p38MAPK combine to improve survival in patients with BRAF mutant colorectal cancer”
title_sort reply to comment of “erk and p38mapk combine to improve survival in patients with braf mutant colorectal cancer”
topic Correspondence
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6189185/
https://www.ncbi.nlm.nih.gov/pubmed/30297771
http://dx.doi.org/10.1038/s41416-018-0275-7
work_keys_str_mv AT roseweirantoniak replytocommentoferkandp38mapkcombinetoimprovesurvivalinpatientswithbrafmutantcolorectalcancer
AT mcmillandonaldc replytocommentoferkandp38mapkcombinetoimprovesurvivalinpatientswithbrafmutantcolorectalcancer
AT edwardsjoanne replytocommentoferkandp38mapkcombinetoimprovesurvivalinpatientswithbrafmutantcolorectalcancer